PodcastThe Directors The Directors: NCORP PIs discuss workforce shortages, expanding workload, and crushing burden of regulatory oversight May 29, 2026Vol.52 No.21By Paul Goldberg and Claire Marie Porter
When CAM is added to standard therapies, survival rates drop, observational study finds May 29, 2026Vol.52 No.21By Jacquelyn Cobb
Trials & Tribulations As rural cancer disparities persist, aligning policy with care delivery models can close the gap May 29, 2026Vol.52 No.21By Matthew L. Anderson
Sponsored UK Markey’s Denise Fabian: Theranostics lets us pair a diagnostic with a radioactive therapeutic that target the same molecule May 29, 2026Vol.52 No.21
Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer May 22, 2026Vol.52 No.20By Paul Goldberg
Conversation with The Cancer Letter Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use May 22, 2026Vol.52 No.20By Paul Goldberg
Capitol HillNCI NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing May 22, 2026Vol.52 No.20By Jacquelyn Cobb
Capitol Hill USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless May 22, 2026Vol.52 No.20By Claire Marie Porter
Guest Editorial UMGCCC neuro-oncologist navigates the reality of his father’s pancreatic cancer May 22, 2026Vol.52 No.20By Haroon Ahmad
Cancer History ProjectFreePodcast “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research HospitalIn a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process May 15, 2026Vol.52 No.19By Claire Marie Porter
